Simulating drug-eluting stents: progress made and the way forward

Sean McGinty; Christopher McCormick; Sean McKee; Marcus Wheel; Simon Kennedy; Keith G. Oldroyd

Simulating drug-eluting stents: progress made and the way forward

Sean McGinty, Christopher McCormick, Sean McKee, Marcus Wheel, Simon Kennedy, Keith G. Oldroyd

Research output: Contribution to conference › Paper

121 Downloads (Pure)

Abstract

Drug-eluting stents have signiﬁcantly improved the treatment of coronary artery disease. Compared with their bare metal predecessors, they offer reduced rates of restenosis and thus represent the current gold standard in percutaneous coronary interventions. Drug-eluting stents have been around for over a decade, and while progress is continually being made, they are not suitable in all patients and lesion types. Furthermore there are still real concerns over incomplete healing and late stent thrombosis. In this paper, some modelling approaches are reviewed and the future of modelling and simulation in this ﬁeld is discussed.

Original language	English
Pages	664-671
Number of pages	8
Publication status	Published - Jul 2013
Event	Special Session on Modelling and Simulation in Biology and Medicine (BIOMED 2013) - Reykajvik, Iceland Duration: 29 Jul 2013 → 31 Jul 2013

Conference

Conference	Special Session on Modelling and Simulation in Biology and Medicine (BIOMED 2013)
Country/Territory	Iceland
City	Reykajvik
Period	29/07/13 → 31/07/13

Keywords

drug-eluting stents
coronary artery disease
progress
bare metal
gold standard

Access to Document

McGintyetalBIOMED2013-simulating-drug-eluting-stentsAccepted author manuscript, 92.9 KB

Cite this

@conference{0729b3cab5c84bc49617edbaa08bc3f3,

title = "Simulating drug-eluting stents: progress made and the way forward",

abstract = "Drug-eluting stents have signiﬁcantly improved the treatment of coronary artery disease. Compared with their bare metal predecessors, they offer reduced rates of restenosis and thus represent the current gold standard in percutaneous coronary interventions. Drug-eluting stents have been around for over a decade, and while progress is continually being made, they are not suitable in all patients and lesion types. Furthermore there are still real concerns over incomplete healing and late stent thrombosis. In this paper, some modelling approaches are reviewed and the future of modelling and simulation in this ﬁeld is discussed.",

keywords = "drug-eluting stents, coronary artery disease, progress, bare metal , gold standard",

author = "Sean McGinty and Christopher McCormick and Sean McKee and Marcus Wheel and Simon Kennedy and Oldroyd, {Keith G.}",

year = "2013",

month = jul,

language = "English",

pages = "664--671",

note = "Special Session on Modelling and Simulation in Biology and Medicine (BIOMED 2013) ; Conference date: 29-07-2013 Through 31-07-2013",

}

TY - CONF

T1 - Simulating drug-eluting stents

T2 - Special Session on Modelling and Simulation in Biology and Medicine (BIOMED 2013)

AU - McGinty, Sean

AU - McCormick, Christopher

AU - McKee, Sean

AU - Wheel, Marcus

AU - Kennedy, Simon

AU - Oldroyd, Keith G.

PY - 2013/7

Y1 - 2013/7

N2 - Drug-eluting stents have signiﬁcantly improved the treatment of coronary artery disease. Compared with their bare metal predecessors, they offer reduced rates of restenosis and thus represent the current gold standard in percutaneous coronary interventions. Drug-eluting stents have been around for over a decade, and while progress is continually being made, they are not suitable in all patients and lesion types. Furthermore there are still real concerns over incomplete healing and late stent thrombosis. In this paper, some modelling approaches are reviewed and the future of modelling and simulation in this ﬁeld is discussed.

AB - Drug-eluting stents have signiﬁcantly improved the treatment of coronary artery disease. Compared with their bare metal predecessors, they offer reduced rates of restenosis and thus represent the current gold standard in percutaneous coronary interventions. Drug-eluting stents have been around for over a decade, and while progress is continually being made, they are not suitable in all patients and lesion types. Furthermore there are still real concerns over incomplete healing and late stent thrombosis. In this paper, some modelling approaches are reviewed and the future of modelling and simulation in this ﬁeld is discussed.

KW - drug-eluting stents

KW - coronary artery disease

KW - progress

KW - bare metal

KW - gold standard

UR - http://www.simultech.org/?y=2013

UR - http://www.scitepress.org/DigitalLibrary/Link.aspx?doi=10.5220/0004622706640672

M3 - Paper

SP - 664

EP - 671

Y2 - 29 July 2013 through 31 July 2013

ER -

Simulating drug-eluting stents: progress made and the way forward

Abstract

Conference

Keywords

Access to Document

Other files and links

Fingerprint

Cite this